Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High‐Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC / MTX

Documenti analoghi

• Outcomes of Post‐Transplant Rh‐ GCSF and Decitabine Maintenance Therapy in Patients With High‐Risk Myeloid Neoplasm
  di: Mathias Palmer, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Combining r‐ ATG With PTCy for GvHD Prophylaxis in Haploidentical HSC Transplantation for Malignancies—A Systematic Review
  di: Joseph M. John, et al.
  Pubblicazione: (2025)
• Clinical Outcomes and Treatment Strategies of Adult Transplant‐Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High‐Risk Criteria
  di: Aldo A. Acosta‐Medina, et al.
  Pubblicazione: (2025)
• Alterations in clinical parameters in cicatrising conjunctivitis secondary to GvHD
  di: Giulia Coco
  Pubblicazione: (2024)
• Increased Plasma ST2 Levels Precede the Development of Severe Acute GvHD and Chronic GvHD After Pediatric Hematopoietic Stem Cell Transplantation
  di: Nakisa Kamari‐Kany, et al.
  Pubblicazione: (2025)